Patents by Inventor Samuel J. Pfaff

Samuel J. Pfaff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC PROTEINS FOR TARGETED DELIVERY OF GROWTH FACTORS TO THE GLOMERULUS
    Publication number: 20240279359
    Abstract: Aspects of the present disclosure relate generally to chimeric proteins and pharmaceutical compositions comprising such chimeric proteins, and methods for using such chimeric proteins for treating kidney diseases. Aspects of the disclosure relate to chimeric protein comprising a targeting domain comprising a scFv having a binding specificity to a cell surface protein of a kidney tissue, and an activator domain comprising a growth factor.
    Type: Application
    Filed: June 30, 2022
    Publication date: August 22, 2024
    Applicant: Silver Creek Pharmaceuticals, Inc.
    Inventors: Kristopher M. Kuchenbecker, Walter Olsen, Samuel J. Pfaff, Yan Zhang, Lakhmir S. Chawla
  • CHIMERIC PROTEINS AND METHODS OF USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
    Publication number: 20240245756
    Abstract: Aspects of the present disclosure relate generally to methods for treating neurodegenerative disorders with chimeric proteins and pharmaceutical compositions comprising such chimeric proteins.
    Type: Application
    Filed: January 19, 2024
    Publication date: July 25, 2024
    Applicant: Silver Creek Pharmaceuticals, Inc.
    Inventors: Kristopher M. Kuchenbecker, Samuel J. Pfaff, Walter Olsen, Lakhmir S. Chawla
  • SLOW-RELEASE CYTOKINE CONJUGATES
    Publication number: 20220193253
    Abstract: This disclosure generally relates to releasable cytokine conjugates and methods of using the same.
    Type: Application
    Filed: April 24, 2020
    Publication date: June 23, 2022
    Applicant: ProLynx LLC
    Inventors: John A. HANGASKY, III, Samuel J. PFAFF, Daniel V. SANTI
  • Chimeric Proteins and Methods of Use for Treatment of Central Nervous System Disorders
    Publication number: 20220031812
    Abstract: Aspects of the present disclosure relate generally to kits and methods for treating acute central nervous systems disorders with chimeric proteins and pharmaceutical compositions comprising such chimeric proteins.
    Type: Application
    Filed: July 30, 2021
    Publication date: February 3, 2022
    Inventors: Samuel J. Pfaff, Yan Zhang, Kristopher M. Kuchenbecker, Lakhmir Chawla